# Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia

> **NCT01239992** · PHASE4 · TERMINATED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 12 (actual)

## Conditions studied

- Hyperlipoproteinemia
- Metabolic Syndrome

## Interventions

- **DRUG:** Niacin/ Laropiprant

## Key facts

- **NCT ID:** NCT01239992
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** negative endpoint study resulting in withdrawal of study drug
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239992, "Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01239992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*